These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32082097)

  • 1. The Incidence of Minor β-thalassemia Among Individuals Participated in Premarital Screening Program in Ardabil Province: North-west of Iran.
    Fathi A; Amani F; Mazhari N
    Mater Sociomed; 2019 Dec; 31(4):294-297. PubMed ID: 32082097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficiency of premarital screening of beta-thalassemia trait using MCH rather than MCV in the population of Fars Province, Iran.
    Karimi M; Rasekhi AR
    Haematologia (Budap); 2002; 32(2):129-33. PubMed ID: 12412732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premarital Screening of Beta Thalassemia Minor in north-east of Iran.
    Hashemizadeh H; Noori R
    Iran J Ped Hematol Oncol; 2013; 3(1):210-5. PubMed ID: 24575266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Couples With MCV≥80, MCH<26, HbA2<3.2, HbF<3 be Classified as Low-risk β-Thalassemia Group?
    Mirzakhani M; Tarrahi MJ; Baghersad A; Maracy MR
    J Pediatr Hematol Oncol; 2019 May; 41(4):303-306. PubMed ID: 30676434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the effect of three β-thalassemia prenatal screening strategies using in Guangdong province].
    Li B; Yin A; Luo M; Wu L; Ma Y; Wang X; Zhang X; Zhao Q
    Zhonghua Fu Chan Ke Za Zhi; 2015 Jun; 50(6):434-40. PubMed ID: 26311551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the validity of the pre-marriage mean corpuscular volume value as a predictive test for b-thalassemia carrier status.
    Almomani AA; Shraim AS; Atoom AM; Abdel MBA; Alhmoud JF
    J Med Biochem; 2023 Mar; 42(2):195-205. PubMed ID: 36987417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The value of MCV, MCH and HbA(2) in laboratory screening of thalassemia].
    Li LY; Li Q; Song LL; Jin WJ; Ma ZH; Yu YH; Zhong M
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):96-100. PubMed ID: 22455739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of β-thalassemia trait and abnormal hemoglobin in premarital screening in the province of Izmir, Turkey.
    Uysal A; Genc A; Taşyürek N; Türkyilmaz B
    Pediatr Hematol Oncol; 2013 Feb; 30(1):46-50. PubMed ID: 23153313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Values of MCV,MCH,ROFT and HbA
    Liu Y; Lin XY; Huang Y; Huang QW; Chen HL; Shen MN; Ruan JY; Li XY; Xu LH; Fang JP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1679-1682. PubMed ID: 33067973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of beta-thalassemia or beta-hemoglobinopathy carriers simultaneously affected with alpha-thalassemia in Iran.
    Alizadeh S; Bavarsad MS; Dorgalaleh A; Khatib ZK; Dargahi H; Nassiri N; Hamid F; Rahim F; Jaseb K; Saki N
    Clin Lab; 2014; 60(6):941-9. PubMed ID: 25016698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Using Mean Corpuscular Volume and Mean Corpuscular Hemoglobin for Beta-thalassemia Carrier Screening in the Guangdong Population of China.
    Gu H; Wang YX; Du MX; Xu SS; Zhou BY; Li MZ
    Biomed Environ Sci; 2021 Aug; 34(8):667-671. PubMed ID: 34474730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of Some Indicators for Alpha-Thalassemia in Fujian Province of Southern China.
    Zheng L; Huang H; Wu X; Su L; Shen Q; Wang M; Lin N; Xu L
    Int J Gen Med; 2021; 14():7329-7335. PubMed ID: 34737627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hepatosplenomegaly in beta thalassemia minor subjects in Iran.
    Karimi M; Bagheri MH; Tahmtan M; Shakibafard A; Rashid M
    Eur J Radiol; 2009 Jan; 69(1):120-2. PubMed ID: 18029131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of beta-thalassemia mutations with alpha-thalassemia: an experience of the southwestern region of Iran.
    Rahim F
    Hematology; 2010 Dec; 15(6):430-3. PubMed ID: 21114907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Screening and Prevention Strategies for Thalassemias and other Hemoglobinopathies of Eastern India: Experience of 18,166 cases.
    Chatterjee T; Chakravarty A; Chakravarty S
    Hemoglobin; 2015; 39(6):384-8. PubMed ID: 26428539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic Screening of Thalassemia among the Couples of Childbearing Age in Ding'an County of Hainan Province and Its Analysis].
    Tu ZH; Wang J; Hu JJ; Zhao LQ; Ran HL; Wang AG; Li YJ; Ma N; Wu Z; Zhou Z
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1592-1595. PubMed ID: 31607317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Large-scale population-based genetic screening and prenatal diagnosis for thalassemias in Zhuhai City of Guangdong Province].
    Zhou YQ; Shang X; Yin BM; Xiong F; Xiao QZ; Zhou WJ; Zhang YL; Xu XM
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):90-5. PubMed ID: 22455738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte indices in a large cohort of β-thalassemia carrier: Implication for population screening in an area with high prevalence and heterogeneity of thalassemia.
    Singha K; Taweenan W; Fucharoen G; Fucharoen S
    Int J Lab Hematol; 2019 Aug; 41(4):513-518. PubMed ID: 31099487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-inheritance of alpha-and beta-thalassemia in Khuzestan Province, Iran.
    Rahim F; Kaikhaei B; Zandian K; Hoseini A
    Hematology; 2008 Feb; 13(1):59-64. PubMed ID: 18534068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amblyopia Prevention Screening Program in Northwest Iran (Ardabil).
    Ojaghi H; Moghaddar R; Ahari SS; Bahadoram M; Amani F
    Int J Prev Med; 2016; 7():45. PubMed ID: 27076883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.